Lumbar Degenerative Disc Disease Treated With Anterior Tension Band System (ATB) With ALIF/FRA Spacer (ATB)

December 15, 2017 updated by: Synthes USA HQ, Inc.

Lumbar Degenerative Disc Disease Treated With

Multi-center, prospective nonrandomized study of treatment for 1 and 2 level degenerative disc disease between L2 and S1. Patients will be followed for a minimum of 2 years.

The primary objective of this study to measure fusion success in patients with lumbar degenerative disc disease using the ATB and ALIF/FRA Spacer. The Secondary objective is evaluation of the patient's quality of life, pain and function.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

178

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. One or Two level (consecutive) degenerative disc disease between L2 and S1. Degenerative disc disease is defined as follows:

    Chronic pain (confirmed by patient exams and history) of discogenic origin, confirmed by radiographic evidence (e.g. MRI, discogram) two or more of the following:

    • Modic type 2 endplate changes on T2 weighted MRI
    • high intensity zone signal on T2 weighted MRI
    • positive discogram with negative controls
    • dark disc (diminished T2 weighted signal)
    • decreased disc height
  2. Has experienced pain, functional deficit and/or neurological deficit for a minimum six month period of time prior to enrollment
  3. Has failed to respond to non-operative treatment modalities for a minimum three month period of time prior to enrollment
  4. Skeletally mature and at least 18 years of age
  5. Signs the approved Informed Consent Document
  6. Is available for long term follow-up and interval visits

Exclusion Criteria:

  1. Has more than 2 levels to be instrumented
  2. Has had a previous fusion attempt at the involved level(s)
  3. Has had more than two previous open, lumbar spine surgical procedures at the involved level(s)
  4. Currently implanted with anterior instrumentation at the involved level(s)
  5. Patient would be classified as morbidly obese BMI > 35
  6. Active localized or systemic infection
  7. Presence of a disease entity or condition which significantly affects the possibility of bony fusion (e.g., osteoporosis, metastatic cancer, long-term use of steroids, etc.)
  8. Has an immunosuppressive disorder
  9. Pregnant or interested in becoming pregnant during the study.
  10. Has a known sensitivity to device materials
  11. Mentally incompetent or prisoner
  12. Currently a participant in another study for the same indications.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Treatment
Interbody fusions with Anterior Plating
allograft spacer + anterior plate
Other Names:
  • ATB
  • Anterior Tension Band

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Subjects With Successful Radiographic Fusion
Time Frame: 24 Months
CT Scans and plain film x-rays will be evaluated. Demonstration of bridging trabecular bone through or external to the allograft spacer will be the measure of success.
24 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life Using the SF-12 Scale Physical Health Component Score (PCS). Number of Subjects Who Achieved 15% Improvement in PCS Compared to Baseline.
Time Frame: 24 Months
Quality of Life using the SF-12 Scale Physical Health Component Score (PCS). The PCS is a measurement of health status with a range of 0-100. A higher score indicates less disability.
24 Months
Pain Scores on the Numeric Rating Scale (NRS)
Time Frame: Baseline and 24 Months
The Numeric Rating Scale (NRS) is a measurement of pain from a value of 0 (no pain) to a value of 10 (worst pain)
Baseline and 24 Months
Oswestry Disability Index (ODI): Number of Subjects Who Achieved a 15% Improvement in ODI Compared to Baseline
Time Frame: 24 Months
The outcome measure is the number of subjects who achieved a 15% improvement in ODI compared to baseline. The ODI is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. ODI scores range from 0 to 100 with 0 equating to No Disability and 100 equating to the Maximum Disability Possible
24 Months
Quality of Life Using SF-12 Scale (MCS): Number of Subjects Who Achieved 15% Improvement in MCS Compared to Baseline
Time Frame: Baseline and 24 Months
The outcome measure is the number of subjects who achieved a 15% improvement in MCS compared to baseline. The MCS (Mental Component Score) is a measurement of health status with a range of 0 to 100. A higher score indicates less disability.
Baseline and 24 Months
SF-12 Physical Composite Score (PCS) Summary
Time Frame: Baseline and 24 Months
The PCS (Physical Component Score) is a measurement of health status with a range of 0 to 100. A higher score indicates less disability.
Baseline and 24 Months
SF-12 Mental Composite Score (MCS) Summary
Time Frame: Baseline and 24 Months
The MCS (Mental Component Score) is a measurement of health status with a range of 0 to 100. A higher score indicates less disability.
Baseline and 24 Months
Oswestry Disability Index (ODI) Summary
Time Frame: Baseline and 24 Months
The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. The scores can range from 0 to 100 with 0 equating to No Disability and 100 equating to the Maximum Disability Possible
Baseline and 24 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kirkham Wood, MD, Mass. General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2004

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

February 1, 2011

Study Registration Dates

First Submitted

March 23, 2011

First Submitted That Met QC Criteria

March 24, 2011

First Posted (Estimate)

March 25, 2011

Study Record Updates

Last Update Posted (Actual)

January 16, 2018

Last Update Submitted That Met QC Criteria

December 15, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 1255

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Degenerative Disc Disease

Clinical Trials on Interbody Fusion

3
Subscribe